REFRACTORY TUMORS

Clinical trials for REFRACTORY TUMORS explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY TUMORS trials appear

Sign up with your email to follow new studies for REFRACTORY TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a Two-Drug combo outsmart childhood cancers that resist treatment?

Disease control Completed

This early-stage trial is testing whether combining two chemotherapy drugs, temozolomide and topotecan, is safe and tolerable for children and adolescents with malignant tumors that have returned or not responded to standard treatments. The study aims to find the highest safe dos…

Matched conditions: REFRACTORY TUMORS

Phase: PHASE1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated Aug 19, 2026 23:00 UTC

REFRACTORY TUMORS

Get alerted when new REFRACTORY TUMORS trials appear

Can a Two-Drug combo outsmart childhood cancers that resist treatment?